ONCOGENE TRANSFORMATION FREQUENCY OF NONSENESCENT SFME CELLS IS INCREASED BY C-MYC

被引:0
|
作者
RAWSON, C [1 ]
SHIRAHATA, S [1 ]
COLLODI, P [1 ]
NATSUNO, T [1 ]
BARNES, D [1 ]
机构
[1] OREGON STATE UNIV,ENVIRONM HLTH SCI CTR,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immortalized, postcrisis mouse embryo cell cultures derived in serum-containing medium display genomic abnormalities and an altered, preneoplastic phenotype. These lines can be transformed with single oncogenes, such as Ha-ras, while efficient transformation of precrisis, genomically unaltered rodent embryo cultures require cooperating oncogenes, such as Ha-ras and the mouse c-myc gene constitutively expressed. Serum-free mouse embryo (SFME) cells, cultured under conditions in which serum is replaced by growth factors and other supplements, are 'immortalized' in the genomically unaltered state. SFME cells do not exhibit growth crisis or gross chromosomal aberration, and are dependent on epidermal growth factor for survival, growth inhibited by serum, and are nontumorigenic. Transformation of SFME cells can be achieved with ras alone, but the introduction of c-myc increased the transfection frequency upon subsequent transfection with ras by as much as twenty fold. Similar results were obtained with mutationally activated neu oncogene and with genomic human tumor DNA. Constitutive expression of c-myc alone did not alter the properties of the SFME cells. These results demonstrate that c-myc alters cellular responses to oncogenes in a culture system in which oncogene-induced immortalization is not a factor, indicating that the effects of myc may extend beyond an 'immortalization' function in these cells.
引用
收藏
页码:487 / 489
页数:3
相关论文
共 50 条
  • [31] c-Myc transrepression and cell transformation
    Lee, LA
    Dang, CV
    C-MYC IN B-CELL NEOPLASIA: 14TH WORKSHOP ON MECHANISMS IN B-CELL NEOPLASIA, 1997, 224 : 131 - 135
  • [32] STRUCTURE OF THE POLYMORPHIC FELINE C-MYC ONCOGENE LOCUS
    SOE, LH
    ROYBURMAN, P
    GENE, 1984, 31 (1-3) : 123 - 128
  • [33] C-MYC ONCOGENE EXPRESSION IN ANAL SQUAMOUS NEOPLASIA
    OGUNBIYI, OA
    SCHOLEFIELD, JH
    ROGERS, K
    SHARP, F
    SMITH, JHF
    POLACARZ, SV
    JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (01) : 23 - 27
  • [34] C-myc oncogene family expression in glioblastoma and survival
    Herms, JW
    von Loewenich, FD
    Behnke, J
    Markakis, E
    Kretzschmar, HA
    SURGICAL NEUROLOGY, 1999, 51 (05): : 536 - 542
  • [35] Amplification of the c-myc oncogene in uveal melanoma.
    Merbs, SL
    Parrella, P
    Caballero, O
    Sidransky, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S109 - S109
  • [36] MECHANISM OF ESTROGEN ACTIVATION OF C-MYC ONCOGENE EXPRESSION
    DUBIK, D
    SHIU, RPC
    ONCOGENE, 1992, 7 (08) : 1587 - 1594
  • [37] HYPOMETHYLATION IN THE C-MYC ONCOGENE IN COLON-CARCINOMA
    LARRIPA, I
    GORLA, N
    GUTIERREZ, M
    BERNEDO, A
    JMELNITZKY, A
    CHOPITA, N
    SLAVUTSKY, I
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1993, 12 (01) : 37 - 40
  • [38] AMPLIFICATION OF THE C-MYC ONCOGENE IN HUMAN STOMACH CANCERS
    NAKASATO, F
    SAKAMOTO, H
    MORI, M
    HAYASHI, K
    SHIMOSATO, Y
    NISHI, M
    TAKAO, S
    NAKATANI, K
    TERADA, M
    SUGIMURA, T
    GANN, 1984, 75 (09): : 737 - 742
  • [39] ANALYSIS OF POLYADENYLATION SITE USAGE OF THE C-MYC ONCOGENE
    LAIRDOFFRINGA, IA
    ELFFERICH, P
    KNAKEN, HJ
    DERUITER, J
    VANDEREB, AJ
    NUCLEIC ACIDS RESEARCH, 1989, 17 (16) : 6499 - 6514
  • [40] ENHANCED EXPRESSION OF C-MYC ONCOGENE IN MAMMARY ADENOCARCINOMAS
    GUERIN, M
    RIOU, G
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 57 - 57